X31

1-{4-[{2-(azonan-1-yl)-6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}(methyl)amino]piperidin-1-yl}ethan-1-one

Created:	2023-10-20
Last modified:	2024-10-23

Find Related PDB Entry
1 entries where X31 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	94
Chiral Atom Count	0
Bond Count	98
Aromatic Bond Count	11

2D diagram of X31

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-{4-[{2-(azonan-1-yl)-6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}(methyl)amino]piperidin-1-yl}ethan-1-one
Systematic Name (OpenEye OEToolkits)	1-[4-[[2-(azonan-1-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-methyl-amino]piperidin-1-yl]ethanone
Formula	C₃₃ H₅₂ N₆ O₃
Molecular Weight	580.804
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CC(=O)N1CCC(CC1)N(C)c1nc(nc2cc(OCCCN3CCCCC3)c(OC)cc21)N1CCCCCCCC1
SMILES	CACTVS	3.385	COc1cc2c(cc1OCCCN3CCCCC3)nc(nc2N(C)C4CCN(CC4)C(C)=O)N5CCCCCCCC5
SMILES	OpenEye OEToolkits	2.0.7	CC(=O)N1CCC(CC1)N(C)c2c3cc(c(cc3nc(n2)N4CCCCCCCC4)OCCCN5CCCCC5)OC
Canonical SMILES	CACTVS	3.385	COc1cc2c(cc1OCCCN3CCCCC3)nc(nc2N(C)C4CCN(CC4)C(C)=O)N5CCCCCCCC5
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(=O)N1CCC(CC1)N(C)c2c3cc(c(cc3nc(n2)N4CCCCCCCC4)OCCCN5CCCCC5)OC
InChI	InChI	1.06	InChI=1S/C33H52N6O3/c1-26(40)38-21-14-27(15-22-38)36(2)32-28-24-30(41-3)31(42-23-13-18-37-16-9-8-10-17-37)25-29(28)34-33(35-32)39-19-11-6-4-5-7-12-20-39/h24-25,27H,4-23H2,1-3H3
InChIKey	InChI	1.06	PHKQQZUOUUSBQB-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	172055178

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.